Cellulitis at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5803-5820

  Halperin, Scott ^a   Kohl, Katrin S ^b   Gidudu, Jane ^b   Ball, Leslie ^c   Hammer, Sandra Jo ^d   Heath, Paul ^e   Hennig, Renald ^f   Labadie, Jerry ^g   Rothstein, Edward ^h   Schuind, Anne ⁱ   Varricchio, Frederick ^c   Walop, Wikke ^j  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f Novartis Vaccine   (Germany)

^g NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

^h Pennridge Pediatric Associates   (United States)

ⁱ GLAXOSMITHKLINE   (United States)

^j PUBLIC HEALTH AGENCY OF CANADA   (Canada)

more..

Author keywords

Adverse event; Case definition; Cellulitis; Guidelines; Immunization

Indexed keywords

VACCINE;

ARTICLE; CASE DEFINITION; CASE STUDY; CLINICAL PRACTICE; CLINICAL RESEARCH; DATA ANALYSIS; DECISION MAKING; DRUG SAFETY; HUMAN; IMMUNIZATION; INJECTION SITE; INJECTION SITE CELLULITIS; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARD;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CELLULITIS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; GUIDELINES; HUMANS; IMMUNIZATION; INJECTIONS; SAFETY;

EID: 34447312492     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.059     Document Type: Article

References (20)

1. Stedman's medical dictionary. 23rd ed. Baltimore: Williams and Wilkins Company; 2003.
2. Stevens D.L. Infections of the skin, muscle and soft tissues. In: Braunwald F., Kasper H., and Longo J. (Eds). Harrison's principals of internal medicine (2001), McGraw Hill Co., New York, NY 821-825
3. Swartz MN. Cellulitis and subcutaneous tissue infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. New York, NY: Churchill Livingstone; 1995, p. 909-29.
4. Melish ME. Bacterial skin infections. In: Feigin C, editor. Textbook of pediatric infectious diseases. 2nd ed. Philadelphia, PA: W.B. Saunders Company; 1987, p. 861-72.
5. Kohl K.S., Gidudu J., Bonhoeffer J., Braun M.M., Michael Buettcher M., Chen R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 25 (2007) 5671-5674
6. Rothstein E., Kohl K.S., Ball L., Halperin S.A., Halsey N., Hammer S.J., et al. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22 (2004) 575-585
7. World Health Organization. Prevention and control of yellow fever in Africa. Geneva: World Health Organization; 1986.
8. World Health Organization. Informal discussions on the use of yellow fever vaccine in Africa. Unofficial report; May 10-11, 1985. World Health Organization; 1985.
9. Oyelami S.A., Olaleye O.D., Oyejide C.O., Omilabu S.A., and Fatunla B.A. Severe post-vaccination reaction to 17D yellow fever vaccine in Nigeria. Rev Roum Virol 45 (1994) 25
10. Ruben F.L., Papageorgiou S.N., Lepow M.L., and Wolinsky E. Perianal vaccinia with associated streptococcal and staphylococcal infection. Arch Derm 99 (1969) 170-175
11. Owensby J.E., Elliot S., Tu K., and Hernandez J.E. Cellulitis and myositis caused by Agrobacterium radiobacter and Haemophilus parainfluenzae after influenza vaccination. S Med J 90 (1997) 752-754
12. Moreno M., Luelmo J., Monteagudo M., Bella R., and Casanovas A. Wells' syndrome related to tetanus vaccine. Int J Dermatol 36 (1997) 524-525
13. Marcy S.M., Kohl K.S., Dagan R., Nalin D., Blum M., Connell Jones M., et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 22 (2004) 551-556
14. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for Clinical Safety assessment (E2a-e). Available on the world wide web: http://www.ich.org/ (last accessed February 9, 2006).
15. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm (last accessed February 9, 2006).
16. CDC. Guidelines for maintaining and managing the vaccine cold chain. MMWR 2003;52:1023-5. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5242a6.htm (last accessed January, 26, 2007).
17. CDC. General Recommendations on Immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55(RR 15):1-48. Also available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm (last accessed January, 26, 2007).
18. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285(15):1987-91. Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm (last accessed February 9, 2006).
19. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354 9193 (1999) 1896-1900. http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006)
20. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283 15 (2000) 2008-2012. http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006)